Proeduca Altus, S.A.
Proeduca Altus, S.A.
Share · ES0105400008 (XMAD)
Overview
No Price
n/a
Share Float & Liquidity
Free Float 7,48 %
Shares Float 3,38 M
Shares Outstanding 45,16 M
Company Profile for Proeduca Altus, S.A. Share
Proeduca Altus, S.A. provides online education services. The company provides its students with a platform designed primarily for management of online learning with resources, such as virtual classrooms, forums, and collaborative work spaces, as well as digital library and virtual museums. Its platform allows its students to contact directly with other classmates, teachers, and tutors from whom they receive educational support and personalized attention. The company serves students in approximately 90 countries primarily in Spain, Ecuador, Colombia, Mexico, Peru, Argentina, Bolivia, and the United States. Proeduca Altus, S.A. is based in Madrid, Spain.
Get up to date insights from finAgent about Proeduca Altus, S.A.

Company Data

Name Proeduca Altus, S.A.
Company Proeduca Altus, S.A.
Website https://www.grupoproeduca.com
Primary Exchange XMAD Madrid
ISIN ES0105400008
Asset Class Share
Sector Consumer Defensive
Industry Education & Training Services
CEO Miguel Tomas Arrufat Pujol
Market Capitalization 1 Mrd.
Country Spain
Currency EUR
Employees 3,4 T
Address Calle Almansa 101, 28040 Madrid
IPO Date 2020-07-27

Ticker Symbols

Name Symbol
Madrid PRO.MC
More Shares
Investors who hold Proeduca Altus, S.A. also have the following shares in their portfolio:
Rama Phosphates Limited
Rama Phosphates Limited Share
The Oncology Institute, Inc. - Common Stock
The Oncology Institute, Inc. - Common Stock Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025